7500 Mendelssohn Ave. N.
55428 Minneapolis, MN, us
+1 (763) 493-7228
Lippke/MOCON names Interautomatika exclusive distributor for Baltic States
Up until now, the Baltics had been serviced out of Lippke's Neuwied, Germany headquarters. An increasing number of instrumentation requests from this region prompted the company to enter into an agreement which would provide enhanced service via local representation.
"Baltic food, beverage and pharmaceutical companies are looking to expand their export potential into other European countries. In order to do so, they need to be able to prove that their products meet the quality standards that have been established in those countries. Investing in leading-edge permeation and leak detection instrumentation helps them meet those goals," said Franz Sturm, managing director, Lippke.
Interautomatika will be representing MOCON/Lippke's extensive line of permeation instrumentation including oxygen, moisture vapor and carbon dioxide testing. Additionally, the company will be selling the Lippke VC 1380 vacuum leak tester for pharmaceutical/ medical packaging applications.
"For the past 10 years, Interautomatika has established a strong reputation as a distributor of industrial equipment and parts. The company has native-speaking employees in all three of the Baltic States. This will provide more customized attention for food, packaging and medical device manufacturers in that region," said Sturm.
Paul Lippke Handels-GmbH, a MOCON company, is the premier European provider of innovative testing instruments and laboratory services to the packaging, pharmaceutical, food, medical device and photovoltaic industries. See www.lippke.com for further information.
This press release contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include but are not limited to: uncertainties relating to competition and technological change, setbacks in product development program, slower-than-anticipated customer acceptance of new products, dependence on certain key industries, risk associated with the Company's acquisition strategy and international operations, and other factors set forth in the Company's filing with the Securities and Exchange Commission.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.